Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹-6.74 Cr₹-6.29 Cr₹4.11 Cr₹13 Cr₹13 Cr

What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH is ₹-6.74 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹-6.74 Cr
Mar2023₹-6.29 Cr
Mar2022₹4.11 Cr
Mar2021₹13 Cr
Mar2020₹13 Cr

How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹-6.74 Cr
Negative
Mar2023 ₹-6.29 Cr
Negative
Mar2022 ₹4.11 Cr
-67.83
Mar2021 ₹13 Cr
-0.23
Mar2020 ₹13 Cr -

Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹547.7 Cr -3.3% -6.2% -12.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,284.0 Cr -0% -0.4% 10.2% Stock Analytics
DIVIS LABORATORIES ₹183,268.0 Cr 1.4% 4.1% 50.3% Stock Analytics
CIPLA ₹122,253.0 Cr 0.5% 1.6% 1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹113,988.0 Cr -1.2% 7.1% 18.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr 1.7% 1.2% 1.5% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-3.3%

-6.2%

-12.6%

SENSEX

-0.7%

3%

5%


You may also like the below Video Courses